Sarepta Therapeutics (SRPT) Q1 2021 Earnings

1MarConfirmed
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-2.4
-1.68
-0.95
-0.23

Details

Expected EPS
-1.92
Actual EPS
-2.4
Surprise EPS
-0.48
Surprise Percent
+25%

Description

Sarepta Therapeutics (SRPT) has reported earnings of -2.4 per share for Q1 2021.

0 Comments

Share your thoughts